Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, Doronin A, Vinogradova E, Yakovlev K, Sivak K, Rudenko L. Isakova-Sivak I, et al. Among authors: krutikova e. Vaccines (Basel). 2022 Jul 18;10(7):1142. doi: 10.3390/vaccines10071142. Vaccines (Basel). 2022. PMID: 35891306 Free PMC article.
Two Live Attenuated Vaccines against Recent Low⁻and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets.
Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Isakova-Sivak I, Donina S, Rekstin A, Pisareva M, Bazhenova E, Kotomina T, Katelnikova A, Muzhikyan A, Makarov V, Sparrow EG, Torelli G. Rudenko L, et al. Among authors: krutikova e. Vaccines (Basel). 2018 Nov 1;6(4):74. doi: 10.3390/vaccines6040074. Vaccines (Basel). 2018. PMID: 30388790 Free PMC article.
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Rekstin A, Donina S, Pisareva M, Grigorieva E, Kryshen K, Muzhikyan A, Makarova M, Sparrow EG, Torelli G, Kieny MP. Rudenko L, et al. Among authors: krutikova e. PLoS One. 2018 Dec 3;13(12):e0208028. doi: 10.1371/journal.pone.0208028. eCollection 2018. PLoS One. 2018. PMID: 30507951 Free PMC article.
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Isakova-Sivak I, Matyushenko V, Kotomina T, Kiseleva I, Krutikova E, Donina S, Rekstin A, Larionova N, Mezhenskaya D, Sivak K, Muzhikyan A, Katelnikova A, Rudenko L. Isakova-Sivak I, et al. Among authors: krutikova e. Vaccines (Basel). 2019 Jul 8;7(3):61. doi: 10.3390/vaccines7030061. Vaccines (Basel). 2019. PMID: 31288422 Free PMC article.
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults.
Kiseleva I, Isakova-Sivak I, Stukova M, Erofeeva M, Donina S, Larionova N, Krutikova E, Bazhenova E, Stepanova E, Vasilyev K, Matyushenko V, Krylova M, Galatonova J, Ershov A, Lioznov D, Sparrow EG, Torelli G, Rudenko L. Kiseleva I, et al. Among authors: krutikova e. Vaccines (Basel). 2020 Jun 10;8(2):296. doi: 10.3390/vaccines8020296. Vaccines (Basel). 2020. PMID: 32532097 Free PMC article.
19 results